Art

J-GLOBAL ID：200902214699231608   Reference number：04A0101450

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

VEGF特異的抗体ベバシズマブのヒト直腸癌における血管新生阻害効果の直接的証明

Author (9)： WILLETT C G (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  BOUCHER Y (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  DI TOMASO E (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  DUDA D G (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  MUNN L L (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  TONG R T (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  CHUNG D C (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  SAHANI D V (Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA) ,  CHEN H X (National Cancer Inst., Maryland, USA)
Material： Nature Medicine  (Nat Med)
Volume： 10  Issue： 2  Page： 145-147  Publication year： Feb. 01, 2004 
JST Material Number： W0636A  ISSN： 1078-8956  Document type： Article
Article type： 短報  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *rectal neoplasm ,...
Semi thesaurus term： *VEGF ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0101450&from=J-GLOBAL&jstjournalNo=W0636A") }}

JST classification (1)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Terms in the title (7)： VEGF ,  抗体 ,  ベバシズマブ ,  ヒト ,  直腸癌 ,  血管新生阻害効果 ,  証明